Matt Belford (@TweetingHeartMD) profile picture

Interventional Cardiologist, Atrium Health Wake Forest Baptist. Opinions my own.

NC, USA
Joined August 2015
Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)Photo by Matt Belford (@TweetingHeartMD)
Matt Belford retweeted
🗓️ Mark your calendars! #SCAI2027 Scientific Sessions will take place May 2–4, 2027 in Fort Lauderdale, Florida. Help shape the agenda with your session suggestions. Submit your ideas before June 9! ➡️ ow.ly/xqZx50YPGJP #InterventionalCardiology #CardioX
17
1
41
3,299
Matt Belford retweeted
“We’re doing more of everything.” - @sahilparikhmd Near-record attendance. Late-breaking science. Hands-on learning. Global collaboration. Hear from Conference Chair Dr. Sahil Parikh on what makes this year stand out. 12 simultaneous publications. Real-world learning. #SCAI2026 is where science meets practice. 🎥 youtu.be/XaGME_xvxCo?si=9uz6…
4
13
1,019
Replying to @SCAI
@SCAI Townhall- Hot Topic: What’s going on with the interventional cardiology match? Do we have too many programs? 25% increase in positions over past 10 years, applications have increased at a rate of 2-3% #SCAI2026
1
7
22
3,425
Matt Belford retweeted
Wrapping up the session, Allison G. Dupont, MD, FSCAI, delivers “ECMO Bootcamp,” covering what every operator needs to know—from fundamentals to practical considerations for managing #ECMO in the cath lab. #InterventionalCardiology #SCAISHOCK #SCAI2026 #CardiogenicShock @BillONeillMD @SrihariNaiduMD @SandeepNathanMD @HeartCountryPCI @thiele_holger @SanjogKalra @AnnGageMD @Babar_Basir @Allison_Dupont @agtruesdell
5
13
537
Matt Belford retweeted
Andrew J. Klein, MD, FSCAI presents #LateBreaking science at #SCAI2026 "Clinical Outcomes of Blood Return During Continuous Aspiration Mechanical Thrombectomy for Pulmonary Embolism: Full Comparative Safety and Efficacy Analysis from ENGULF" Read the summary ➡️ scai.org/media-center/news-a… #InterventionalCardiology #CardioX @MyJSCAI @djkereiakes @SuzanneJBaron @Agoldsweig @SandeepNathanMD @HenrytTimothy @kalazizimd @dehghani_payam @SammyElmariahMD
1
6
10
528
Matt Belford retweeted
Who says wellness has to be serious? Out and about in SCAI Central, attendees at #SCAI2026 are boosting their wellbeing the best way we know how… by laughing at truly terrible cardiology dad jokes 😄 Stenty fully approves. Questionable punchlines, excellent vibes. 🎥 Watch if you dare. #SCAIWellness #AdventuresOfStenty
3
1
24
2,948
Matt Belford retweeted
👍 What a great great meeting 🇨🇦🇺🇸 : @SCAI has come soooo far since I first joined…
3
14
1,004
UnitedHealth @UHC just had its biggest quarterly earnings EVER. They do this by denying care and not paying those who deliver care. They put profits above patients. I urge every patient or employer to drop them immediately. Enough is enough.
208
668
47
2,655
74,015
This is really well done. Small and labor intensive but congrats to team for a well done study. #acc26
Finally, a sham-controlled CTO PCI trial—and it delivers. ORBITA-CTO: small (n=50), but rigor where it matters—blinding, placebo control, symptom-level data. CTO PCI improves angina beyond placebo, with a clear reduction in episodes and more angina-free days. Not prognosis, not hard endpoints, but real symptom benefit—properly measured. #acc26 jacc.org/doi/10.1016/j.jacc.…
57
Matt Belford retweeted
Finally, a sham-controlled CTO PCI trial—and it delivers. ORBITA-CTO: small (n=50), but rigor where it matters—blinding, placebo control, symptom-level data. CTO PCI improves angina beyond placebo, with a clear reduction in episodes and more angina-free days. Not prognosis, not hard endpoints, but real symptom benefit—properly measured. #acc26 jacc.org/doi/10.1016/j.jacc.…
6
108
10
319
34,920
DISCOVER INOCA study: In this prospective multicenter U.S. registry, invasive coronary function testing identified a coronary vasomotor disorder in 94% and reclassified the pre-procedure diagnosis in 89% of cases, supporting its use in patients with symptomatic INOCA. #ACC26 View the slides here: clinicaltrialresults.org/wp-…
1
29
59
4,770
Matt Belford retweeted
#ACC26 Much awaited Door to Unload trial for Anterior MI failed to show the benefit for Impella. Unload before Revasc for Ant MI. Surprisingly mean BP ~140 despite LVEDP in high 20s!
6
41
1
117
12,885
Matt Belford retweeted
MRA for HFrEF ✅ Lifesaving (1999, 2011) ✅ Class 1, LOE A guideline recommended ✅ Cost <$40 per year 🆘 Yet large, persistent treatment gap in the US GWTG-HF MRA use 🏨 discharge 2005 27.4% 202480.9% +53.5%, adjusted OR 22.3 🎉 Major progress (finally) 🚜 More to do
4
12
42
2,753
New Orleans is buzzing and so is #ACC26! 🎺 Good morning, New Orleans! Kick off Day 1⃣ with 📹 What’s Brewing at #ACC26 today ☕️ and get the inside scoop on today’s highlights, sessions, and experiences you won’t want to miss.
11
1
55
9,806
Matt Belford retweeted
Native PCI vs graft PCI after PROCTOR? RCT obviously doesn’t support native first, also no reflow is a lot lower for SVG PCI in contemporary trial vs perceived. Next question is to coil the SVG vs leave it open post native CTO PCI? Data free zone. @djc795 #CTO2026
8
6
39
3,693
Matt Belford retweeted
Replying to @djc795
@djc795 at #CTO2026. CHiP operators vs Trialists. Very interesting comparison, great learning about why non inferiority design of trials. @jedicath @Babar_Basir @CathWhisperer @SarahFairley7 @CathWhisperer @MinaFar20 @MichaelMegalyMD @Shoaib9702 @Tabaza @PSandesara_MD @SripalBangalore @realarainmd
5
1
21
4,043
What to look for in non-inferior trials? Very short and succinct talk by @djc795 Next year he deserves a 30 minute talk @crfheart #CTO2026 We never got to the WIN ratio 😭
1
6
19
1,320
Gary mintz with a masterclass around imaging in Calcium - angiography underestimates presence of Ca and overestimates presence of severe Ca and need for Ca modification - validatted scores for oct and ivus in guiding need for Ca modification @SCAI
1
11
41
2,595